Tuesday, 19 August 2014
Lost days due to stress rise by 70%
Lost days due to stress rise by 70% Sickness caused by stress rises by 70% among East of England public sector workers over five years, the BBC finds. BBC Northamptonshire
Nice one NICE: developing the policy narrative on preventing disability, frailty and dementia in later life
Nice one NICE: developing the policy narrative on preventing disability, frailty and dementia in later life As we commemorate the 100th anniversary of the outbreak of the First World War, it is easy to forget that in 1914, UK life expectancy at birth was only 49 for men and 53 for women. Advances in societal wealth, nutrition, employment, environmental health, housing, perinatal care and preventative and curative medical treatment mean that the era in which those servicemen and their families lived is almost unrecognisable. Life-expectancy is now 79 for men and 83 for women, and when we reach the age of 65 we can expect to live another two decades on average.
Living longer lives is a cause for celebration but there are still major inequalities in life expectancy and healthy life expectancy at birth, in rates of premature deaths, and in life expectancy at 65 between different socioeconomic groups. We also face a rising prevalence of long-term conditions, dementia, disability and frailty related to rapid population ageing, which has big implications both for individuals and for health and social care systems.
Living longer lives is a cause for celebration but there are still major inequalities in life expectancy and healthy life expectancy at birth, in rates of premature deaths, and in life expectancy at 65 between different socioeconomic groups. We also face a rising prevalence of long-term conditions, dementia, disability and frailty related to rapid population ageing, which has big implications both for individuals and for health and social care systems.
Guidance: Who to screen for MRSA
Guidance: Who to screen for MRSA The guidance, from the Expert Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI), recommends a more efficient and effective method for identifying and managing high-risk patients who have tested positive for MRSA. However, NHS Trusts need to take into account local risks as well as the recommendations so they can get the best results in their hospitals.
This guidance draws on the outputs of the National One Week (NOW) study and could be used to inform policy making decisions should the prevalence of MRSA increase. Department of Health
This guidance draws on the outputs of the National One Week (NOW) study and could be used to inform policy making decisions should the prevalence of MRSA increase. Department of Health
VIDEO: The debate over competition in the NHS
VIDEO: The debate over competition in the NHS Recent large contracts are fuelling the debate over competition for services within the NHS. BBC News
VIDEO: Inside Liberia Ebola treatment centre
VIDEO: Inside Liberia Ebola treatment centre Following earlier denials, Liberia has admitted that 17 suspected Ebola patients are "missing" after a health centre in the capital was looted. BBC News
See also:
See also:
Records access may reduce GP pressures
Records access may reduce GP pressures Giving patients access to their GP records can reduce demand for traditional appointments and telephone calls to practices, a research study has suggested. E-Health Insider
Bone marrow drug could treat alopecia
Bone marrow drug could treat alopecia “Alopecia sufferers given new treatment hope with repurposed drug,” The Guardian reports.
Alopecia is a type of autoimmune condition where the body’s own immune cells start to attack the hair follicles for an unknown reason, leading to hair loss.
This new research actually involved two phases, one involving mice and one involving humans.
The researchers identified the specific type of immune cell (CD8+NKG2D+ T cells) that is involved in this autoimmune process, and identified the signalling pathways that stimulate the activity of these cells.
The researchers then demonstrated that using molecular treatments to block these signalling pathways was effective in preventing and reversing the disease process in mice genetically engineered to develop alopecia.
These findings in mice were followed by promising results in three people with moderate to severe alopecia. These people were treated with ruxolitinib, which is currently licensed in the UK to treat certain bone marrow disorders. All three patients demonstrated “near-complete hair regrowth” after three to five months of treatment.
Alopecia is a type of autoimmune condition where the body’s own immune cells start to attack the hair follicles for an unknown reason, leading to hair loss.
This new research actually involved two phases, one involving mice and one involving humans.
The researchers identified the specific type of immune cell (CD8+NKG2D+ T cells) that is involved in this autoimmune process, and identified the signalling pathways that stimulate the activity of these cells.
The researchers then demonstrated that using molecular treatments to block these signalling pathways was effective in preventing and reversing the disease process in mice genetically engineered to develop alopecia.
These findings in mice were followed by promising results in three people with moderate to severe alopecia. These people were treated with ruxolitinib, which is currently licensed in the UK to treat certain bone marrow disorders. All three patients demonstrated “near-complete hair regrowth” after three to five months of treatment.
Child mental health bed boost
Child mental health bed boost NHS England to make more beds available following sustained criticism of child mental health services. OnMedica
Antibiotics wrongly prescribed by many GPs, survey finds
Antibiotics wrongly prescribed by many GPs, survey finds Doctors giving out antibacterial medication, even when unnecessary, to satisfy patients or cover uncertain diagnosis
Almost half of British GPs have admitted prescribing antibiotics even though they know they will not treat the patients condition, a survey shows.
Ninety per cent of doctors who responded to a recent questionnaire said they felt pressure from patients to hand out the antibacterial medication. Continue reading... The Guardian
Almost half of British GPs have admitted prescribing antibiotics even though they know they will not treat the patients condition, a survey shows.
Ninety per cent of doctors who responded to a recent questionnaire said they felt pressure from patients to hand out the antibacterial medication. Continue reading... The Guardian
Subscribe to:
Posts (Atom)